MindImmune - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeMindImmune
MindImmune logo

MindImmune

0 followers

About MindImmune

MindImmune Therapeutics, Inc. is a company that specializes in developing novel therapeutics targeting the immune system to treat brain disease. They have made a fundamental discovery that implicates the peripheral immune system in the pathology of Alzheimer's disease and are developing a therapeutic antibody to block the immune attack on the brain.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Stevin Zorn, PhD

President and Chief Executive Officer

Frank S. Menniti, PhD

Chief Science Officer

Key Facts

HQ Location

Kingston, United States

Founded

2016

Employees

11 - 50

Status

Private

Website

https://mindimmune.com